GlassScriptPhysician profile
Timothy J Lin
NPI 1124213715
$10,382.58
in general payments reported to CMS, 2019-2025
47 companies · $883 in 2025
The $883 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,417 · 2020: $1,536 · 2021: $1,169 · 2022: $1,582 · 2023: $1,655 · 2024: $1,141 · 2025: $883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,104 · Consulting Fee: $400 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,103.88 |
| Consulting Fee | $400.00 |
| Education | $174.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,773.06 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,151.63 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Astrazeneca Pharmaceuticals LP | $985.18 | 2019-2024 | Breztri, Fasenra, Airsupra |
| Olympus Corporation of The Americas | $787.55 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $636.75 | 2019-2024 | |
| Mallinckrodt Hospital Products INC. | $595.80 | 2020-2025 | Acthar |
| Actelion Pharmaceuticals US, INC. | $515.48 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Grifols USA, LLC | $398.22 | 2019-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $386.87 | 2019-2024 | Yupelri |
| Insmed, INC. | $253.26 | 2019-2025 | Arikayce, Brinsupri |
| Regeneron Healthcare Solutions, INC. | $224.14 | 2019-2025 | Dupixent |
| United Therapeutics Corporation | $212.56 | 2019-2025 | Tyvaso, Tyvaso |
| Harmony Biosciences LLC | $202.31 | 2022-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $195.43 | 2019-2021 | |
| Amgen INC. | $193.01 | 2022-2025 | Tezspire |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $155.24 | 2019-2024 | |
| Teva Pharmaceuticals USA, INC. | $143.74 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $125.23 | 2019-2025 | Winrevair |
| Mallinckrodt Enterprises LLC | $114.81 | 2019 | |
| Genentech USA, INC. | $114.20 | 2019-2022 | |
| Verona Pharma, INC. | $109.61 | 2025 | Ohtuvayre |
| Sunovion Pharmaceuticals INC. | $96.77 | 2019-2020 | |
| Resmed Corp | $92.23 | 2023-2025 | |
| Gilead Sciences, INC. | $74.83 | 2019-2022 | |
| Viatris Specialty LLC | $71.22 | 2025 | Yupelri |
| Covis Pharma Gmbh | $68.67 | 2022 | |
| Pfizer INC. | $66.32 | 2021-2025 | |
| Electromed, INC. | $62.46 | 2019-2023 | Smartvest |
| Advanced Respiratory, INC | $60.89 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $53.59 | 2024 | Purified Cortrophin Gel |
| Fisher & Paykel Healthcare INC | $49.65 | 2024-2025 | Fisher & Paykel Healthcare |
| Circassia INC. | $45.50 | 2019-2020 | |
| Inari Medical, INC. | $41.22 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Shire North American Group INC | $38.44 | 2019 | |
| Abbvie INC. | $36.56 | 2021-2023 | |
| Philips North America LLC | $36.11 | 2022-2024 | (Ak6) Vest Therapy |
| Inogen, INC. | $33.90 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Takeda Pharmaceuticals U.S.A., INC. | $33.86 | 2022 | |
| La Jolla Pharmaceutical Company | $19.15 | 2023 | Giapreza |
| Eisai INC. | $18.40 | 2020 | |
| Olympus America INC. | $18.29 | 2022 | |
| Csl Behring | $16.82 | 2019 | |
| Inspire Medical Systems, INC. | $16.45 | 2025 | Inspire |
| Allergan, INC. | $15.08 | 2019 | |
| Pulmonx Corporation | $14.79 | 2023 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Lilly USA, LLC | $14.53 | 2025 | Zepbound |
| Alexion Pharmaceuticals, INC. | $12.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.